Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawkins, R. A.
Right arrow Articles by Phelps, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawkins, R. A.
Right arrow Articles by Phelps, M. E.
NEUROLOGY 1987;37:1707
© 1987 American Academy of Neurology

Wilson's disease studied with FDG and positron emission tomography

Randall A. Hawkins, MD, PhD, John C. Mazziotta, MD, PhD and Michael E. Phelps, PhD

Department of Radiological Sciences, Division of Nuclear Medicine and Biophysics (Drs. Hawkins, Mazziotta, and Phelps), and the Department of Neurology (Dr. Mazziotta), UCLA School of Medicine; and the Laboratory of Nuclear Medicine, Laboratory of Biomedical and Environmental Sciences (Operated for the US Department of Energy by the University of California under Contract #DE-AC03-76-SF00012), Los Angeles, CA.

Four patients with Wilson's disease and eight normal controls were studied with 2-deoxy-2-[18F]fluoro-d-glucose (FDG) and positron emission tomography (PET). The patients had diffusely reduced glucose metabolism in all brain regions evaluated compared with controls, with the exception of the thalamus. The ratio of the cerebral metabolic rate for glucose in the lenticular nuclei to hemispheres declined from 1.23 (± 0.14 SD) in controls to 1.03 (± 0.06) (p < 0.025) in Wilson's disease patients. Compared with Huntington's disease, the PET FDG results in Wilson's disease indicate relatively less focal involvement of the caudate nucleus, more severe focal changes in the lenticular nuclei, and more significant global changes in glucose metabolism.

Address correspondence and reprint requests to Dr. Hawkins, Division of Nuclear Medicine and Biophysics, UCLA School of Medicine, Los Angeles, CA 90024.

Supported in part by the Director of the Office of Energy Research, Office of Health and Environmental Research, and by NIH grmts NS20867, NS15654, and MH37916.

Presented in part at the thirty-fifth annual meeting of the American Academy of Neurology, San Diego, CA, April 1983.

Received September 17, 1986. Accepted for publication in final form February 11, 1987.




This article has been cited by other articles:


Home page
J Child NeurolHome page
L. A. O'Tuama, D. P. Dickstein, R. Neeper, and G. G. Gascon
Topical Review: Functional Brain Imaging in Neuropsychiatric Disorders of Childhood
J Child Neurol, April 1, 1999; 14(4): 207 - 221.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.